Back to Search
Start Over
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.
- Source :
-
Annals of neurology [Ann Neurol] 2012 Sep; Vol. 72 (3), pp. 395-405. - Publication Year :
- 2012
-
Abstract
- Objective: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that presents with variable pathologies that may reflect different disease-causing mechanisms. Existing animal models of MS induce pathology using either local injection of gliotoxins or stimulation of the immune system with myelin-related peptides. In none of these models is the primary cellular target well characterized, and although demyelination is a hallmark pathological feature in MS, it is unclear to what extent this reflects local oligodendrocyte loss. To unambiguously identify the effects of oligodendrocyte death in the absence of inflammatory stimulation, we developed a method for experimentally inducing programmed cell death selectively in mature oligodendrocytes and assessed the effects on demyelination, immunological stimulation, and gliosis. The resulting pathology is discussed relative to observed MS pathologies.<br />Methods: Oligodendrocyte apoptosis was induced in the adult rat brain using a lentivirus to express experimentally inducible caspase 9 (iCP9) cDNA under transcriptional control of the promoter for myelin basic protein, which is oligodendrocyte-specific. Activation of iCP9 was achieved by distal injection of a small molecule dimerizer into the lateral ventricle resulting in localized, acute oligodendrocyte apoptosis.<br />Results: Induced oligodendrocyte apoptosis resulted in rapid demyelination and robust, localized microglial activation in the absence of peripheral immune cell infiltration. Lesion borders showed layers of preserved and degraded myelin, whereas lesion cores were demyelinated but only partially cleared of myelin debris. This resulted in local proliferation and mobilization of the oligodendrocyte progenitor pool.<br />Interpretation: This approach provides a novel model to understand the pathological changes that follow from localized apoptosis of myelinating oligodendrocytes. It provides the first direct proof that initiation of apoptosis in oligodendrocytes is sufficient to cause rapid demyelination, gliosis, and a microglial response that result in lesions sharing some pathological characteristics with a subset of MS lesions.<br /> (Copyright © 2012 American Neurological Association.)
- Subjects :
- Animals
Apoptosis genetics
Apoptotic Protease-Activating Factor 1 metabolism
Basic Helix-Loop-Helix Transcription Factors metabolism
Brain cytology
Brain drug effects
Caspase 9 genetics
Caspase 9 metabolism
Cell Count
Cells, Cultured
Demyelinating Diseases chemically induced
Demyelinating Diseases metabolism
Disease Models, Animal
Enzyme Activation
Gangliosides metabolism
Glial Fibrillary Acidic Protein
Gliotoxin pharmacology
Green Fluorescent Proteins genetics
Green Fluorescent Proteins metabolism
Immunosuppressive Agents pharmacology
Myelin Basic Protein
Nerve Tissue Proteins metabolism
O Antigens metabolism
Oligodendrocyte Transcription Factor 2
Protein Multimerization drug effects
Rats
Tacrolimus pharmacology
Transduction, Genetic methods
Transfection methods
Apoptosis physiology
Brain metabolism
Brain pathology
Demyelinating Diseases pathology
Oligodendroglia physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1531-8249
- Volume :
- 72
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Annals of neurology
- Publication Type :
- Academic Journal
- Accession number :
- 23034912
- Full Text :
- https://doi.org/10.1002/ana.23606